Short Term Outcomes Of Bipolar Prostate Resection (BPR) Versus Diode Laser Ablation Versus Holmium Laser Enucleation Of Prostate Above 80 Grams With Minimum One Year Follow Up Duration.

Randomized Controlled Study Comparing Safety, Efficacy and Short Term Outcomes Of Bipolar Prostate Resection (BPR) Versus Diode Laser Ablation Versus Holmium Laser Enucleation Of Prostate Above 80 Grams With Minimum One Year Follow Up Duration.

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07410390

Enrollment

105

Registered

2026-02-13

Start date

2026-02-20

Completion date

2026-12-30

Last updated

2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia With Outflow Obstruction

Brief summary

Detailed description

comparing three different techniques for treatment of prostatomegaly (BPH) bipolar resection of the prostate versus diode laser ablation of the prostate versus holmium laser enucleation monitoring preoperative data . intraoperative data , postoperative outcomes and long term outcomes within 1 year of the operation aiming to decide which technique has the superior hand over other regarding large size prostate above 80 grams

Interventions

PROCEDUREbipolar resection of the prostate

bipolar resection of the prostate

PROCEDUREholimum laser enucleation of the prostate

holimum laser enucleation of the prostate

PROCEDUREdiode laser ablation of the prostate

diode laser ablation of the prostate

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

55 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Refractory LUTS secondary to benign prostatic hyperplasia (BPH) * Acute retention secondary to BPH who failed medical treatment * Prostate size above 80 gm in Pelvi-Abdominal ultrasound or Trans-Rectal ultrasound

Exclusion criteria

* Suspected Neurogenic bladder. * Suspected Prostatic adenocarcinoma (either by digital rectal examination or high PSA level) * Urinary bladder carcinoma * urethral stricture. previous bladder, urethral or prostate surgery. * Bleeding tendency. * Uncontrolled bleeding disorders.

Design outcomes

Primary

Measure	Time frame	Description
time to catheter removal	within the first 1 week post-operatively	number of days to catheter removal post-operatively

Secondary

Measure	Time frame	Description
removed prostatic tisuue	within the first month postoperatively	assessment of prostate size by Pelviabdominal ultrasound and wight of the removed prostatic tissues in grams

Contacts

CONTACTamr ahmed said elsawy, urology specialist

amr.elasawy@med.asu.edu.eg01222543421

CONTACTamr said elsawy, urologist

amrsaideldoc2020@gmail.com01096907834

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026